Prosecution Insights
Last updated: May 29, 2026

Examiner: ADAMS, MICHELLE

Tech Center 1700 • Art Units: 1777 1797

This examiner grants 58% of resolved cases

Performance Statistics

58.5%
Allow Rate
-6.5% vs TC avg
586
Total Applications
+40.4%
Interview Lift
1314
Avg Prosecution Days
Based on 568 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
11.9%
§102 Novelty
48.4%
§103 Obviousness
29.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17960629 PHOTOACTIVATABLE VIBRATIONAL PROBES AND USES THEREOF Non-Final OA California Institute of Technology
17280936 POLYMERIC CHROMOPHORES, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME Final Rejection North Carolina State University
16556397 Colorimetric Detection of Organic Amines Using Metal-Organic Frameworks Final Rejection The Johns Hopkins University
17606759 METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE Final Rejection Encodia, Inc.
17738399 Methods for Determining Equivalent Alkane Carbon Number Non-Final OA Colgate-Palmolive Company
17424265 ADVANCED METHODS FOR AUTOMATED HIGH-PERFORMANCE IDENTIFICATION OF CARBOHYDRATES AND CARBOHYDRATE MIXTURE COMPOSITION PATTERNS AND SYSTEMS THEREFORE AS WELL AS METHODS FOR CALIBRATION OF MULTI WAVELENGTH FLUORESCENCE DETECTION SYSTEMS THEREFORE, BASED ON NEW FLUORESCENT DYES Final Rejection MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V
18036797 FLUORESCENT SENSORS Non-Final OA THE UNIVERSITY OF SYDNEY
18432898 METHOD FOR ANALYZING BY-PRODUCTS OF RNA IN VITRO TRANSCRIPTION Non-Final OA CureVac Manufacturing GmbH
17769353 METHOD OF DIAGNOSING EARLY-STAGE NON-SMALL CELL LUNG CANCER Non-Final OA BIOMARK CANCER SYSTEMS INC.
17587940 MODEL FOR EVALUATING DEGREE OF LIVER FIBROSIS CONSTRUCTED BASED ON BILE ACIDS Non-Final OA Zhejiang Provincial People's Hospital
17616707 METHOD AND SENSOR FOR DETECTION OF TRIACETONE TRIPEROXIDE (TATP), DIACETONE DIPEROXIDE (DADP), HEXAMETHYLENE TRIPEROXIDE DIAMINE (HMTD) AND HYDROGEN PEROXIDE Final Rejection Institut Dr. Foerster GmbH & Co. KG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month